[1]
Anu Grover, Eknath Pawar, G. K. Singh, Ashok Gupta, Anil Pareek, Rujul Desai and Indranil Purkait 2022. Aceclofenac, a Preferential COX-2 Inhibitor - Appraisal of Safety and Tolerability. Journal of Evolution of Medical and Dental Sciences. 11, 7 (Jun. 2022), 690–698. DOI:https://doi.org/10.14260/jemds.v11i7.148.